SPR Therapeutics has received SPR Therapeutics ( Sprint Peripheral Nerve Stimulation ) clearance for an update of its wearable SPR Therapeutics pain management device. The Cleveland -based company said the device would now be available as single or dual lead, able to use rechargeable batteries, and be Bluetooth-enabled. The device is a percutaneous electrical nerve stimulator, and involves a wire being placed through a patient’s skin to target nerve fibres and relieve pain. It can be used for eight weeks . SPR said the placement was reversible and would be ideal for shorter outpatient procedures.
SPR Therapeutics has received Food and Drug Administration (FDA) clearance for an update of its wearable Sprint Peripheral Nerve Stimulation pain management device. The Ohio-based company said the device would now be available as single or dual lead, able to use rechargeable batteries, and be Bluetooth-enabled. The device is a percutaneous electrical nerve stimulator, and involves a wire being placed through a patient’s skin to target nerve fibres and relieve pain. It can be used for up to 60 days. SPR said the placement was reversible and would be ideal for shorter outpatient procedures.